0001209191-16-110843.txt : 20160328
0001209191-16-110843.hdr.sgml : 20160328
20160328214711
ACCESSION NUMBER: 0001209191-16-110843
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160322
FILED AS OF DATE: 20160328
DATE AS OF CHANGE: 20160328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330971591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 CAMBRIDGE AVE
STREET 2: SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-272-6138
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVE
STREET 2: SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cory David A
CENTRAL INDEX KEY: 0001670137
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 161533495
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-03-22
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001670137
Cory David A
350 CAMBRIDGE AVE, SUITE 350
PALO ALTO
CA
94306
1
1
0
0
President and CEO
Common Stock
56889
D
Common Stock
30350
I
See footnote 1
Stock Option (right to buy)
1.38
2023-09-24
Common Stock
17504
D
Stock Option (right to buy)
2.06
2025-09-22
Common Stock
74393
D
Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.
The option vests in equal monthly installments over 48 months measured from September 24, 2013 subject to Reporting Person's continuous service status as of each such date.
The option will vest as to 25% of the option shares on September 22, 2016 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.
/s/ David Cory
2016-03-22